- Bladder side effects were experienced half as often with CyberKnife SBRT as with conventional linear accelerator delivered SBRT two years after treatment SUNNYVALE, Calif., Sept. 14, 2021 ...

SUNNYVALE, Calif., Dec. 15, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has received approval from the Japanese Ministry of Health, Labor and Welfare (Shonin) to market ...

MADISON, Wis., April 3, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data on the clinical use of the CyberKnife ® System reinforce the device's broad-based ...

Medical Team's Use of Accuray CyberComm™ Reduced Commissioning Time by Approximately 50 Percent*, Enabling Them to Initiate Patient Treatments Sooner The CyberKnife System facilitates ...

SUNNYVALE, Calif., June 17, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has launched the CyberKnife ® S7™ System, an innovative device combining speed, ...

Auckland Radiation Oncology Selected the Latest-Generation CyberKnife S7™ System to Deliver Precise Treatments More Quickly, so Patients Can Rapidly Return to the Activities They Enjoy SUNNYVALE, ...

We recently upgraded Accuray Inc. (ARAY) to Neutral. The stock was assigned a target price of $7.50 based on a P/S of 1.8x our fiscal 2011 sales estimate of $236 million. Accuray reported a second ...

Accuray Incorporated ARAY recently received approval from the Japanese Ministry of Health, Labor and Welfare (Shonin) with respect to marketing the CyberKnife Robotic Radiosurgery System in Japan.

(RTTNews) - Accuray Inc. (ARAY) said data from the Prostate Advances in Comparative Evidence or PACE trial indicated that the company's CyberKnife robotic radiotherapy platform is superior to ...